Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Hisamitsu Pharmaceutical Co Inc | 12 |
| 2 | Xerox Corp | 6 |
| 3 | Alivio Therapeutics Inc | 5 |
| 4 | Kaneka Corp | 5 |
| 5 | Reckitt Benckiser Healthcare UK Ltd | 5 |
| 6 | Roche Diagnostics GmbH | 5 |
| 7 | Roxro Pharma Inc | 4 |
| 8 | Takeda Pharmaceutical Co Ltd | 4 |
| 9 | AbbVie Inc | 3 |
| 10 | Methylgene Inc | 3 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 79 |
| 2 | A61P | Therapeutic activity (drug indications) | 63 |
| 3 | C07D | Heterocyclic compounds | 29 |
| 4 | A61L | Sterilising / disinfecting materials | 20 |
| 5 | G01N | Investigating / analysing materials | 20 |
| 6 | A61N | 13 | |
| 7 | C07C | Acyclic and carbocyclic compounds | 13 |
| 8 | C08L | Polymer compositions (blends) | 12 |
| 9 | G01K | 12 | |
| 10 | C09D | Coatings, paints, varnishes | 9 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Dental Anxiety and Anesthesia Techniques | 7 |
| 2 | Methemoglobinemia and Tumor Lysis Syndrome | 5 |
| 3 | Contact Dermatitis and Allergies | 3 |
| 4 | Advancements in Transdermal Drug Delivery | 2 |
| 5 | Crystallization and Solubility Studies | 2 |
| 6 | Gastroesophageal reflux and treatments | 2 |
| 7 | Neonatal Health and Biochemistry | 2 |
| 8 | Advanced Chemical Sensor Technologies | 1 |
| 9 | Airway Management and Intubation Techniques | 1 |
| 10 | Analytical Chemistry and Chromatography | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | B J Meakin | University of Bath | 9 |
| 2 | Eneida de Paula | Universidade Estadual de Campinas (UNICAMP) | 9 |
| 3 | Edurne Aguado | University of the Basque Country | 3 |
| 4 | Cíntia Maria Saia Cereda | Universidade Estadual de Campinas (UNICAMP) | 5 |
| 5 | E. W. Ackerman | Radboud University Nijmegen | 5 |
| 6 | Elliot V. Hersh | University of Pennsylvania | 5 |
| 7 | A. M. Rabasco | Universidad de Sevilla | 4 |
| 8 | Alberto Lesarri | Universidad de Valladolid | 4 |
| 9 | D. D. Breimer | University of Applied Sciences Leiden | 4 |
| 10 | Diane J. Burgess | University of Connecticut | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Multiple hormonal activities of UV filters and comparison of in vivo and in vitro estrogenic activity of ethyl-4-aminobenzoate in fish | 2006 | 327 | Pharmaceutical and Antibiotic Environmental Impacts |
| Strong influence of El Niño Southern Oscillation on flood risk around the world | 2014 | 301 | Climate variability and models |
| Drug Release from Compressed Hydrophilic Matrices | 1968 | 257 | Drug Solubulity and Delivery Systems |
| Protomers of Benzocaine: Solvent and Permittivity Dependence | 2015 | 219 | Mass Spectrometry Techniques and Applications |
| Estrogenic activity of UV filter mixtures | 2006 | 195 | Effects and risks of endocrine disrupting chemicals |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the chemical composition of Neutracaine?
Which organizations hold the most patents related to Neutracaine?
What are the main research topics associated with Neutracaine?
How much scholarly and patent coverage does Neutracaine have?
What are the dominant patent classification categories for Neutracaine?